Criminal activity surrounding the manufacture, distribution and sale of falsified medicines is “on the rise” as a global health problem in many developing countries and in rich nations – especially online – but efforts to stem the growing health threat will require robust collective action by all stakeholders, a top Novartis official warned Friday in […] Continue reading ->
The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading ->
For the first time ever, leading cancer organizations across Latin America have signed onto a joint declaration pledging to intensify action against millions of avoidable cancer deaths on the continent. The Bogota Statement on Leading BOLD Cancer Prevention into the Future was signed by leaders of cancer organizations and foundations from 8 Latin American countries, […] Continue reading ->
Madrid – Exceptional global heat waves, retreating ice sheets and record sea levels – all driven by rising concentrations of atmospheric greenhouse gases – are the hallmark of the past decade as 2019 draws to a close, said the World Metereological Organization (WMO) on Tuesday. The global average temperature in 2019 (January to October) was […] Continue reading ->
For the second year running, some 37 organizations have launched a week-long mini campaign to raise awareness and promote action against falsified and substandard medicines.  This year’s annual Fight the Fakes week aims to mobilize the public and international global health community to speak up more assertively about the growing threat of fake or substandard […] Continue reading ->
[Drugs for Neglected Diseases Initiative] Geneva, Switzerland (29 November 2019) – The Indian pharmaceutical company Cipla has announced their commitment to price the ground-breaking new product Quadrimune, a “4‑in‑1” treatment for young children with HIV, at below a dollar a day. Quadrimune is currently under review by the US Food and Drug Administration (FDA) for use in children […] Continue reading ->
African leaders, scientists, and activists are mobilizing to address the scientific, political, and social challenges inherent to ending the HIV epidemic. That was the key message as the 20th International Conference on AIDS and STIs in Africa (ICASA) kicked off on Monday in Kigali, Rwanda under the theme, “AIDS-free Africa: Innovation, Community and Political Leadership.” […] Continue reading ->